However, recent studies from different research groups demonstrated the oncogenic roles of IGF2BP1 in breast cancer, maintaining the glycolysis and stemness of BCSCs through IGF2BP1/c-Myc axis 55, 56, promoting proliferation of breast cancer cells 57 and contributing the progression of breast cancer 58. Here, MYC is linked to breast carcinoma.